References
- Habeshaw JA. Specialized laboratory methods. Lymph node biopsy interpretations, A G Stansfeld. Churchill Livingstone, London 1985; 44–46
- Genetic rearrangements in leukemia and lymphoma, J M Goldman, D G Marnden. Churchill Livingstone, London 1986, Leukemia and lymphoma research 2.
- Lennert K. Classification of non-Hodgkin's lymphomas. Malignant lymphomas other than Hodgkin's disease, K Lennert, N Mohri, H Stein, E Kaiserling, H K Muller-Hermeling. Springer-Verlag, Berlin 1987; 83–110, Histology, cytology, ultrastructure, immunology.
- Carbone P P, Kaplan H S, Musshoff K, Smithers D W, Tubiana M. Report of the committee of Hodgkin's disease staging classification. Cancer Res 1971; 31: 1860–1
- Lukes R J, Carver L F, Hall TC. Report of the nomenclature committee. Cancer Res 1966; 26: 1311
- Norberg G, Dige U, Roos G, Johansson H, Lenner P. Hodgkin's disease in Northern Sweden 1971 - 1981. II. A retrospective analysis of prognostic factors. Acta Oncol 1991; 30: 597–601
- Norberg B, Dige U, Roos G, Johansson H, Lenner P. Hodgkin's disease in Northern Sweden 1971–1981. III. the clinical and prognostic impact of age. Acta Oncol 1991; 30, (Accepted for publication)
- Lee ET. Statistical methods for survival data analysis. Belmont Lifetime Learning Publ. 1980; 75–156
- Pinkus G S, Thomas P, Said JW. Leu-MI A marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues. Am J Pathol 1985; 119: 244–52
- Symers W. Survey of the eventual diagnosis in 600 cases referred for second histologic opinion. J Clin Pathol 1968; 21: 650–3
- Hancock B W, Aitken M, Martin J F, et al. Hodgkin's disease in Sheffield (1971–76) (with computer analysis of variables). Clin Oncol 1979; 5: 283–97
- Miller T P, Byrne G E, Jones SE. Mistaken clinical and pathological diagnoses of Hodgkin's disease: A Southwest Oncology Group study. Cancer Treat Rep 1982; 66: 645–51
- Nordentoft A M, Pedersen-Bjergaard J, Brincler H, et al. Hodgkin's disease in Denmark. A national clinical study in the Danish Hodgkin study group. LYGRA. Scand J Haematol 1980; 24: 321–34
- Franssila K O, Heiskala M K, Heiskala HJ. Epidemiology and histopathology of Hodgkin's disease in Finland. Cancer 1977; 39: 1280–8
- Stein H, Gerdes J, Schwab U, et al. Identification of Hodgkin and Reed-Stemberg cells as a unique cell type derived from a newly detected small-cell population. Int J Cancer 1982; 30: 445–59
- Schwab U, Stein H, Gerdes J, et al. Production of a monoclonal antibody specific for Hodgkin and Reed-Sternberg cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 1982; 299: 65–7
- Sheibani K S, Battifora H, Burke J S, Rappaport H. Leu-M1 antigen in human neoplasms. An immunohistoiogic study of 400 cases. Am J Surg Pathol 1986; 10: 227–36
- Rosenberg SA. Current concepts in cancer: Non-Hodgkin's lymphomas—selection of treatment on the basis of histologic type. N Engl J Med 1979; 301: 924–8
- DeVita V T, Canellos C P, Chabner B, Schein P, Hubbard S P, Young RC. Advanced diffuse histiocytic lymphoma, a potentially curable disease. Results with combination chemotherapy. Lancet 1975; 1: 248–50
- Brittinger B, Bartels H, Common H, et al. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas—results of a prospective multicenter study by the Kiel lymphoma study group. Hematol Oncol 1984; 2: 269–306